INVESTIGADORES
EIJAN Ana Maria
artículos
DEBORA N. FRYDRYK BENITEZ; MÓNICA A. PALMIERI; YANINA V. LANGLE; ANDREA MONTI HUGHES; EMILIANO C. C. POZZI; SILVIA I. THORP,; MARCELA A. GARABALINO, ANDREA MONTI HUGHES,1,2 PAULA CUROTTO,1, IARA S. SANTA CRUZ,1 PAULA RAMOS,1 M.E. ITOIZ; PAULA S. RAMOS,; MARÍA L. PAPARELLA; LUCAS POLTI; ANA EIJÁN; AMANDA E. SCHWINT; VERÓNICA A. TRIVILLIN,
Therapeutic Efficacy, Radiotoxicity and Abscopal Effect of BNCT at the RA-3 Nuclear Reactor Employing Oligo-Fucoidan and Glutamine as Adjuvants in an Ectopic Colon Cancer Model in Rats
LIFE; Lugar: Basel; Año: 2023 vol. 13
MARTIN A. MERENZON, ; ELSA HINCAPIE ARIAS,; SHOVAN BHATIA, ; ASHISH H. SHAHA,; DOMINIQU E M.O. HIGGINS; MARCELA VILLAVERDE, ; DENISE BELGOROSKY, ; ANA M. EIJÁN
 Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review
NITRIC OXIDE-BIOLOGY AND CHEMISTRY; Lugar: Amsterdam; Año: 2023 vol. 138 p. 10 - 16
AGÜERO, EDUARDO IMANOL; BELGOROSKY, DENISE; GARCÍA-SILVA, JULIO ISRAEL; BOOTH, ROSS; LERNER, BETIANA; PÉREZ, MAXIMILIANO SEBASTIÁN; EIJÁN, ANA MARÍA
Microdevices for cancer stem cell culture as a predictive chemotherapeutic response platform
JOURNAL OF MOLECULAR MEDICINE (BERLIN, GERMANY); Año: 2023
YASSINE OUFQIR, ; LAURIE FORTIN, ; JULIE GIROUARD, ; FRANCIS CLOUTIER, ; MAUDE CLOUTIER, ; MARIE-FRANCE LECLERC, ; DENISE BELGOROSKY,; ANA MARÍA EIJÁN, ; GERVAIS BÉRUBÉ, ; CARLOS REYES-MORENO
Synthesis of new para-aminobenzoic acid derivatives, in vitro biological evaluation and preclinical validation of DAB-2-28 as a therapeutic option for the treatment of bladder cancer
European Journal of Medicinal Chemistry Reports; Lugar: Paris; Año: 2022 vol. 6
CATALINA LODILLINSKY; LAETITIA FUHRMANN ; MARIE IRONDELLE ; OLENA PYLYPENKO .; XIAO-YAN LI ; HÉLÈNE BONSANG-KITZIS ; FABIEN REYAL ; SOPHIE VACHER ; CLAIRE CALMEL ; OLIVIER DE WEVER ; IVAN BIÈCHE ; MARIE-LISE LACOMBE ; ANA MARIA EIJAN; ANNE HOUDUSSE ; ANNE VINCENT-SALOMON ; STEPHEN J. WEISS ; PHILIPPE CHAVRIER ; MATHIEU BOISSAN
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance
ONCOGENE; Lugar: Londres; Año: 2021
CHANPHAI P., ; CLOUTIER F., ; OUFQIR Y., ; LECLERC M.-F., ; EIJAN A.M., ; REYES-MORENO C., ; BERUBE G., ; TAJMIR-RIAHI H.A
Biomolecular study and conjugation of two para-aminobenzoic acid derivatives with serum proteins: drug binding efficacy and protein structural analysis
Journal of Biomolecular Structure and Dynamics; Año: 2021 vol. 39 p. 79 - 90
VERÓNICA A. TRIVILLIN, ; YANINA V. LANGLE, ; MÓNICA A. PALMIERI, ; EMILIANO C.C. POZZI, ; SILVIA I. THORP, ; DEBORA N. BENITEZ FRYDRYK,; MARCELA A. GARABALINO, ; ANDREA MONTI HUGHES, ; PAULA M. CUROTTO, ; LUCAS L. COLOMBO, ; IARA S. SANTA CRUZ, ; PAULA S. RAMOS, ; MARÍA E. ITOIZ,; CLAUDIA ARGÜELLES, ; ANA M. EIJÁN ; AMANDA E. SCHWINT
Evaluation of local, regional and abscopal effects of Boron Neutron Capture Therapy (BNCT) combined with immunotherapy in an ectopic colon cancer model
THE BRITISH JOURNAL OF RADIOLOGY.; Año: 2021
GIROUARD J,; BELGOROSKY D ; HAMELIN-MORRISSETTE J,; BOULANGER V; D'ORIO E; RAMLA D ; PERRON R ; CHARPENTIER L ; VAN THEMSCHE C ; EIJÁN AM,; BÉRUBÉ G; REYES-MORENO C,
Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways
BIOCHEMICAL PHARMACOLOGY; Lugar: Amsterdam; Año: 2020
P. CHANPHAI; F. CLOUTIER; Y. OUFQIR ; M.-F. LECLERC; A.M. EIJÁN ; C. REYES-MORENO; G. BÉRUBÉ ; H.A. TAJMIR-RIAHI
Biomolecular study and conjugation of two paraaminobenzoic acid derivatives with serum proteins: drug binding efficacy and protein structural analysis.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS; Año: 2020
YANINA.VERÓNICA LANGLE ; N.P. BALARINO; D. BELGOROSKY ; PABLO CRESTA MORGADO; E.O. SANDES; L. MARINO ; E.R. BILBA ; M. ZAMBRANO; C. LODILLINSKY ; ANA.MARÍA EIJÁN
Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment
NITRIC OXIDE-BIOLOGY AND CHEMISTRY; Lugar: UTHA; Año: 2020
DENISE BELGOROSKY; ; JULIE GIROUARD, ; YANINA VERONICA LANGLE, ; JOVANE HAMELIN-MORRISSETE; ; LINA MARINO; ; EDUARDO IMANOL AGÜERO; ; HÉCTOR MALAGRINO, ; CARLOS REYES-MORENO, ; ANA MARÍA EIJÁN,
Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
JOURNAL OF MOLECULAR MEDICINE (BERLIN, GERMANY); Lugar: Berlin; Año: 2020
MARÍA VICTORIA MENCUCCI ; LARA LAPYCKYJ ; MARINA ROSSO ; MARÍA JOSÉ BESSO ; DENISE BELGOROSKY ,; MARIANA ISOLA ; SILVIA VANZULLI ; CATALINA LODILLINSKY; ANA MARÍA EIJÁN ; JUAN CARLOS TEJERIZO ; MATÍAS IGNACIO GONZALEZ ; MARÍA ERCILIA ZUBIETA; MÓNICA HEBE VAZQUEZ-LEVIN
Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples
FRONTIERS OF RADIATION THERAPY AND ONCOLOGY; Lugar: Basel; Año: 2020
ALBERT?, MARINA; CUELLO, HECTOR; GULINO, CYNTHIA; PIFANO, MARINA; BELGOROSKY, DENISE; GABRI, MARIANO; EIJ?N, ANA; SEGATORI, VALERIA
Expression of bladder cancer‑associated glycans in murine tumor cell lines
Oncology Letters; Lugar: Atenas; Año: 2019 vol. 17 p. 3141 - 3150
SCIACCA M, ; BELGOROSKY D, ; ZAMBRANO M, ; GOMEZ ESCALANTE JI, ; ROCA F, ; LANGLE YV, ; SANDES EO, ; LODILLINSKY C,; EIJÁN AM
Inhibition of breast tumor growth by N(G)-nitro-l-arginine methyl ester (l-NAME) is accompanied by activation of fibroblasts.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY; Lugar: Amsterdam; Año: 2019
CORMICK, BARBARA PRACK MC; LANGLE, YANINA; BELGOROSKY, DENISE; VANZULLI, SILVIA; BALARINO, NATALIA; SANDES, EDUARDO; EIJÁN, ANA MARÍA
Flavonoid Silybin improves the response to radiotherapy in invasive bladder cancer
JOURNAL OF CELLULAR BIOCHEMISTRY; Lugar: New York; Año: 2018
BELGOROSKY, DENISE; FERNÁNDEZ-CABADA, TAMARA; PEÑAHERRERA-PAZMIÑO, ANA BELÉN; LANGLE, YANINA; BOOTH, ROSS; BHANSALI, SHEKHAR; PÉREZ, MAXIMILIANO S.; EIJÁN, ANA MARÍA; LERNER, BETIANA
Analysis of tumoral spheres growing in a multichamber microfluidic device
JOURNAL OF CELLULAR PHYSIOLOGY; Lugar: New York; Año: 2018
BARBARA PRACK MC CORMICK, ; DENISE BELGOROSKY, ; YANINA LANGLE, ; NATALIA BALARINO, ; EDUARDO SANDES,; ANA MARIA EIJAN
1. Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer
NITRIC OXIDE-BIOLOGY AND CHEMISTRY; Lugar: Amsterdam; Año: 2017
YANINA V. LANGLE ; DENISE BELGOROSKY ,; BÁRBARA PRACK MC CORMICK ; ANA SAHORES ; ADRIÁN GÓNGORA ; ALBERTO BALDI; CLAUDIA LANARI ; CAROLINE LAMB ; ANA MARÍA EIJÁN; EIJAN A M
FGFR3 down-regulation is involved in BCG-induced bladder tumor growth inhibition
JOURNAL OF UROLOGY; Año: 2016 vol. 195 p. 188 - 197
KRASNAPOLSKI MARTIN ALEJANDRO, ; LODILLINSKY CATALINA, ; BAL DE KIER JOFFE ELISA ; EIJAN ANA MARIA
Hypoxia-induced Nitric Oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Lugar: New York; Año: 2015 vol. 141 p. 1727 - 1738
HAMELIN-MORRISSETTE J, ; CLOUTIER S, ; GIROUARD J, ; BELGOROSKY D, ; EIJAN ANA MARIA; LEGAULT J, ; REYES-MORENO C, ; BÉRUBÉ G.
2. Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells
EUROPEAN JOURNAL OF MEDICAL CHEMISTRY; Lugar: Paris; Año: 2015 vol. 96 p. 259 - 268
DENISE BELGOROSKY; YANINA LANGLE; BÁRBARA PRACK MC CORMICK ; LUCAS COLOMBO ; EDUARDO SANDES ; ANA MARÍA EIJÁN
Inhibition of Nitric Oxide is a Good Therapeutic Target for Bladder Tumors that express iNOS.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY; Año: 2014 vol. 36 p. 11 - 18
L. GÁNDARA; E. SANDES ; G. DI VENOSA ; B. PRACK MC CORMICK ; L. RODRIGUEZ ; L. MAMONE ; A. BATLLE ; A.M. EIJÁN ; A. CASAS
The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY; Año: 2014 vol. 133 p. 55 - 64
YANINA LANGLE ; EDUARDO SANDES ; DENISE BELGOROSKY,; NATALIA BALARINO, ; BÁRBARA PRACK MC CORMICK; LINA MARINO ; ERICA ROJAS BILBAO ; HÉCTOR MALAGRINO ; LEONARDO PASIK ; ALBERTO CASABÉ ; ANA MARÍA EIJÁN
La expresion de S100A9, vinculada con el óxido nítrico, es un marcador de mal pronóstico en pacientes con cáncer de vejiga, siendo su inhibición un posible blanco terapeutico
REVISTA ARGENTINA DE UROLOGIA (1990); Lugar: Buenos Aires; Año: 2014 vol. 79 p. 64 - 70
EL BEHI ; SOPHIE KRUMEICH ; CATALINA LODILLINSKY; AURE´LIE KAMOUN; LORENZO TIBALDI ; GAEL¨ SUGANO ; AURE´LIEN DE REYNIES ; ELODIE CHAPEAUBLANC ; AGNE`S LAPLANCHE; THIERRY LEBRET ; YVES ALLORY ; FRANC¸OIS RADVANYI ; OLIVIER LANTZ; ANA MARIA EIJAN; ISABELLE BERNARD-PIERROT ; CLOTILDE THÉRY
An essential role for decorin in bladder cancer invasiveness
EMBO Mol Med; Año: 2013 vol. 5 p. 1 - 17
EDUARDO O. SANDES, ; CATALINA LODILLINSKY ; YANINA LANGLE.; DENISE BELGOROSKY, ; LINA MARINO, ; LILIANA GIMENEZ, ; ALBERTO R. CASABÉ, ; ANA MARIA EIJAN
Inducible Nitric Oxide Syntahse and Peroxisome Proliferator-Activated Receptor gamma are involved in bladder cancer progresión.
JOURNAL OF UROLOGY; Lugar: NY; Año: 2012 vol. 188 p. 967 - 973
VICTORIA T. FABRIS; CATALINA LODILLINSKY; MARÍA BETINA PAMPENA ; DENISE BELGOROSKY; CLAUDIA LANARIA ; ANA MARÍA EIJÁN
Cytogenetic characterization of the murine bladder cancer model MB49 and the invasive MB49-I derived line
CANCER GENETICS AND CYTOGENETICS; Año: 2012 vol. 205 p. 168 - 176
YANINA LANGLE, ; CATALINA LODILLINSKY, ; DENISE BELGOROSKY, ; EDUARDO OMAR SANDES, ; ANA MARÍA EIJÁN
Role of Peroxisome Proliferator Activated Receptor gamma (PPARg) in BCG bladder cancer therapy.
JOURNAL OF UROLOGY; Lugar: NY; Año: 2012 vol. 188 p. 2384 - 2390
CATALINA LODILLINSKY; YANINA LANGLE; ARIEL GUIONET; ADRIÁN GÓNGORA; ALBERTO BALDI; EDUARDO O. SANDES; ALBERTO CASABÉ; ANA MARÍA EIJÁN
Bacillus Calmette Guerin Induces Fibroblast Activation Both Directly and through Macrophages in a Mouse Bladder Cancer Model
PLOS ONE; Lugar: PARIS FRANCIA; Año: 2010 vol. 5 p. 1 - 11
CATALINA LODILLINSKY; VANINA RODRIGUEZ; LILIANA VAUTHAY; EDUARDO SANDES; ALBERTO CASABÉ; ANA MARIA EIJAN
Novel invasive orthotopic bladder cancer model with high catepsin B activity resembling human bladder cancer disease
JOURNAL OF UROLOGY; Lugar: Official Journal of the American Urological Association; Año: 2009 vol. 182 p. 1749 - 1755
EDUARDO SANDES, CATALINA LODILLINSKY, RUTH CWIRENBAUM CLAUDIA ARGÜELLES, ALBERTO CASABÉ, ANA MARÍA EIJÁN; CATALINA LODILLINSKY; RUTH CWIRENBAUM; CLAUDIA ARGÜELLES; ALBERTO CASABÉ; ANA MARIA EIJAN
Cathepsin B (CB) is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette Guerin (BCG) in transitional cancer cell (TCC) lines
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: atemas; Año: 2007 vol. 20 p. 823 - 828
LODILLINSKY, CATALINA; UMEREZ, MARIA SOL; JASNIS, MARIA ADELA; CASABE, ALNERTO; SANDES, EDUARDO; EIJAN, ANA MARIA
Bacillus Calmette-Guerin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: Atenas; Año: 2006 vol. 17 p. 269 - 273
ALVAREZ, VALERIA; LODILLINSKY, CATALINA; UMEREZ, SOL; SANDES, EDUARDO; EIJAN ANA MARIA
Inhibition of bacillus Calmette-Grérin-induced nitric oxide in bladder tumor cells may improve BCG treatment
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: Athenas; Año: 2005 vol. 16 p. 565 - 571
BERTOLESI, GABRIEL; EIJAN ANA MARIA; CALVO, JUAN CARLOS; LAURIA DE CIDRE, LILIA
Heparin increases the adhesion of murine mammary adenocarcinoma cells (LM3). Correlation with the presence of heparin receptors on cell surface.
Journal Biological Regulators Homeostatic Agents; Lugar: Roma, Italia; Año: 2005 vol. 19 p. 33 - 40
SANDES, EDUARDO O; FALETTE, IALICIA G.; . RIVERROS, MARÍA D; VIDAL, MARÍA DEL C; GIMENEZ, LILIANA; CASABÉ, ALBERTO R; EIJÁN, ANA MARÍA
Expression of inducible nitric oxide synthase in tumoral and non tumoral epithelia from bladder cancer patientes
NITRIC OXIDE-BIOLOGY AND CHEMISTRY; Lugar: Oxford; Año: 2005 vol. 12 p. 39 - 45
ANA MARIA EIJAN; EDUARDO O. SANDES; MARÍA D. RIVEROS; SEBASTIÁN THOMPSON; LEONARDO PASIK; HÉCTOR MALAGRINO; FRANCISCO CELESTE; ALBERTO R. CASABÉ
high expression of cathepsin B in transitional bladder cancer correlates with tumor invasion
CANCER; Año: 2003 vol. 98 p. 262 - 268
A.ESPAÑOL,; A.M.EIJÁN,; ESTEVAN MASSONI,; L.DAVEL,; M.A.JASNIS,; E.S. DE LUSTIG,; M.E.SALES
Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: Athenas 11635, Grecia; Año: 2002 vol. 9 p. 651 - 657
ANA MARÍA EIJÁN,; I.PICCARDO,; M.D.RIVEROS,; E.O.SANDES,; H.PORCELLA,; H.RUEDA,; M.A.JASNIS,; E.S. DE LUSTIG,; H.MALAGRINO,; L.PASIK,; A.R.CASABÉ
Nitric oxide in transitional bladder cancer patients
JOURNAL OF SURGICAL ONCOLOGY; Lugar: New York; Año: 2002 vol. 8 p. 2003 - 2008
L.DAVEL,; ANA M EIJÁN; M.E.SALES,; A.ESPAÑOL,; A.DAGOSTINO,; I.PICCARDO,; L.LAURÍA,; E.SACERDOTE DE LUSTIG,; M.A.JASNIS
Reactivity of tumor draining lymph nodes and the nitric oxide pathway
INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Athenas; Año: 2002 vol. 20 p. 59 - 67
AR CASABÉ,; I PICCARDO ,; M RIVEROS,; EDUARDO O. SANDES,; MA JASNIS,; L PASIK,; H MALAGRINO,; H PORCELLA,; AM CHIRIFE,; ES DE LUSTIG ,; AM EIJÁN
Niveles elevados de óxido nítrico en orina como indicador de presencia de tumor transicional de vejiga
REVISTA ARGENTINA DE UROLOGIA (1990); Año: 2002 vol. 67 p. 11 - 17
S GALLI,; LL COLOMBO,; S VANZULLI,; MC DAROQUI,; MC VIDAL,; MA JASNIS,; ES DE LUSTIG,; AM EIJÁN
Selección de una línea tumoral (LM2) con menor capacidad metastásica que el tumor parental
La Prensa Médica Argentina; Año: 2002 vol. 87 p. 539 - 543
G.ROZENBERG,; J.ESPADA,; L.LAURIA DE CIDRE,; ANA MARÍA EIJÁN,; G.E.BERTOLESI
Heparan sulfate, heparin, and heparinase activity detection on polyacrylamide gel electrophoresis using the fluorochrome tris (2,2’-bipyridine) ruthenium (II)
ELECTROPHORESIS; Año: 2001 vol. 22 p. 3 - 11
S.GALLI,; L.COLOMBO,; S.VANZULI,; M.C.DAROQUI,; M.C.VIDAL,; M.A.JASNIS,; E.S.DE LUSTIG,; AM EIJÁN,
Characterization of a fibroblastoid mammary carcinoma cell line (LM2) originated from a mouse adenocarcinoma
INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Athenas; Año: 2000 vol. 17 p. 1259 - 1265
M.A.PICCONI,; ANA MARÍA EIJÁN,; A.L.DISTEFANO,; S.PUEYO,; L.V.ALONIO,; S.GOROSTIDI,; A.R.TEYSSIÉ,; A.R.CASABÉ
Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: Analysis of primary tumors and lymph nodes
JOURNAL OF MEDICAL VIROLOGY; Año: 2000 vol. 61 p. 65 - 69
A.M.EIJAN,; E.SANDES,; L.PURICELLI,; E.BAL DE KIER JOFFÉ,; A.R.CASABÉ
Cathepsin B in urine of bladder cance patientes
ONCOLOGY REPORTS; Lugar: Athenas; Año: 2000 vol. 7 p. 1395 - 1399
M.L.CERUTTI,; E.DORIO,; L.DAVEL,; L.COLOMBO,; P.PARMA,; M.DIAMENT,; I.STILLITANI,; M.E.GELPI,; S.LEICACH,; A M EIJÁN,
A synthetic nitrogenated antimetastatic and anti-angiogenic compound with low toxicity in vivo
INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 1999 vol. 14 p. 585 - 591
A.M.EIJÁN,; L.DAVEL ,; H.A.RUEDA,; G.ROZENBERG,; E.S.DE LUSTIG,; M.A.JASNIS
Differential nitric oxide release and sensitivity to injury in different murine mammary tumor cell lines
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: ATHENAS; Año: 1998 vol. 2 p. 625 - 630
A.M. EIJÁN,; A. CASABÉ,; L.PURICELLI,; L. PASIK,; H. MALAGRINO,; E. MATOS,; E. BAL DE KIER JOFFÉ
Levels of plasma cysteine-proteinase activity in bladder cancer patients
ONCOLOGY REPORTS; Lugar: ATHENAS; Año: 1997 vol. 4 p. 447 - 450
L.PURICELLI,; M. DE LORENZO,; A.M. EIJÁN,; H. MALAGRINO,; S. KES,; L. PASIK,; E.MATOS,; E.BAL DE KIER JOFFÉ,; A.R.CASABÉ
Increased levels of urinary basic fibroblast growth factor in bladder cancer patients
ONCOLOGY REPORTS; Lugar: ATHENAS; Año: 1997 vol. 4 p. 619 - 622
G.E.BERTOLESI,; E.F.FARÍAS,; D.F.ALONSO,; E.BAL DE KIER JOFFÉ,; L.S.LAURIA DE CIDRE,; A.M.EIJÁN
Insight into the profibrinolytic activity of heparin: effects on the activation of plasminogen mediated by urokinase
BLOOD COAGULATION & FIBRINOLYSIS : AN INTERNATIONAL JOURNAL IN HAEMOSTASIS AND THROMBOSIS.; Año: 1997 vol. 8 p. 403 - 410
F.K. GUERRA,; A.M. EIJÁN,; L. PURICELLI,; D.F. ALONSO,; E. BAL DE KIER JOFFE,; A. KORNBLIHTT,; E.H. CHARREAU,; P.V. ELIZALDE
Varying patterns of expression of insulin-like growth factors I and their receptors in murine mammary adenocarcinomas of different metastasizing ability
INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 1996 vol. 65 p. 1 - 10
D. ALONSO,; G.E. BERTOLESI,; E. FARIAS,; A.M. EIJÁN,; E. BAL DE KIER JOFFE,; L. LAURIA DE CIDRE
Antimetastatic effects associated with anticoagulant properties of heparin and chemically modified heparin species in a mouse mammary tumor model
ONCOLOGY REPORTS; Lugar: ATHENAS; Año: 1996 vol. 3 p. 219 - 222
L. LAURIA DE CIDRE,; A.M. EIJÁN,; G. BERTOLESI,; M. ISTURIZ,; E. S. DE LUSTIG
Influence of mast cells on two murine mammary adenocarcinomas
TUMOR BIOLOGY; Año: 1996 vol. 17 p. 345 - 356
G.BERTOLESI,; L.LAURIA,; E. S. DE LUSTIG,; A.M.EIJÁN
Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability. Relationship with growth inhibition
CANCER LETTERS; Año: 1995 vol. 90 p. 123 - 131
GE BERTOLESI,; L LAURIA DE CIDRE,; E SACERDOTE DE LUSTIG,; AM EIJÁN
3. Efecto antiproliferativo de la heparina
Prensa Médica Argentina; Año: 1995 vol. 82 p. 357 - 362
A.M.EIJÁN,; L.PURICELLI,; E.BAL DE KIER JOFFÉ,; C.ELIAS,; S.R.LEICACH,; R.A.CADENAS
Action of nitrogenated and sulfonylated inositol derivatives upon the proliferation in vitro of normal mouse and tumor mouse cells
TUMOR BIOLOGY; Año: 1994 vol. 15 p. 354 - 360
G. BERTOLESI,; L. LAURIA,; E.S.DE LUSTIG,; A.M.EIJÁN
Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins
TUMOR BIOLOGY; Año: 1994 vol. 15 p. 275 - 283
L. PURICELLI,; D. GOMEZ,; M. DEL C. VIDAL,; A M EIJÁN,; O. SPINELLI,; D. ALONSO,; E. FARIAS,; E. BAL DE KIER JOFFÉ
Effect of host organ enviromment on the in vivo and in vitro behaviour of murine mammary adenocarcinoma
TUMOR BIOLOGY; Año: 1994 vol. 15 p. 284 - 293
A.M.EIJÁN,; L. DAVEL,; E.S. DE LUSTIG
Modulación de la angiogénesis inducida por linfocitos, por proteínas de la matriz extracelular
Acta Physiol Pharmacol Ther Latinoam; Lugar: CAPITAL FEDERAL; Año: 1993 vol. 43 p. 53 - 57
A.M.EIJÁN,; L.DAVEL,; S.OISGOLD-DAGÁ,; E.S.DE LUSTIG
Modulation of tumor-induced-angiogenesis by proteins of extracellular matrix
Molecular Biotherapy; Año: 1991 vol. 3 p. 38 - 40
A.M.EIJÁN,; S.OISGOLD-DAGÁ
Neutralization activity on tumor growth by xenogeneic anti-spleen cell supernatant sera.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR.; Año: 1990 vol. 9 p. 205 - 210
E.BAL DE KIER JOFFÉ,; A.M.EIJÁN,; S.OISGOLD-DAGÁ
Effect of soluble spleen factors on in vitro growth of tumoral cells
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR.; Año: 1990 vol. 9 p. 139 - 143
EIJÁN AM,; BAL DE KIER JOFFE E.
Cathepsins: their role in tumor invasiveness
MEDICINA; Lugar: BUENOS AIRES; Año: 1990 vol. 50 p. 171 - 174
A.M.EIJÁN,; S.OISGOLD-DAGÁ
Production of tumor enhancing factors in a murine system
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR.; Año: 1989 vol. 8 p. 193 - 198
A.M.EIJÁN,; M.A.JASNIS,; A.B.MOTTA,; S.OISGOLD-DAGÁ
Isolated soluble fractions from spleen cell culture supernatants induce tumor enhancement
JOURNAL OF SURGICAL ONCOLOGY; Año: 1989 vol. 41 p. 134 - 138
YP DE BONAPARTE,; LL COLOMBO,; L DAVEL,; M DIAMENT,; AM EIJÁN,; MA JASNIS,; S KLEIN,; I STILLITANI
Inmunoregulation of tumor growth in a murine model
MEDICINA (BUENOS AIRES); Año: 1989 vol. 49 p. 265 - 270
E.BAL DE KIER JOFFÉ,; L.PURICELLI,; R.MARIOTTO,; A.M.EIJÁN,; E.S.DE LUSTIG
Fibronectin and laminin in breast cancer and lymph node metastases. Lack of correlation with fibronectin plasmatic levels
MEDICINA (BUENOS AIRES); Año: 1988 vol. 48 p. 499 - 505
A.B.MOTTA,; A.M.EIJÁN,; S.KLEIN,; Y.P.DE BONAPARTE
Characterization and partial purification of the active fraction from a soluble tumor murine extract
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR.; Año: 1988 vol. 7 p. 127 - 131
G.M.SCHIAVI,; A.M.EIJÁN,; M.A.JASNIS,; S.OISGOLD-DAGÁ
Monitoring of Circulating Immune Complexes during tumor development. Effect on tumor growth
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR.; Año: 1988 vol. 7 p. 73 - 78
L.DAVEL,; M.MIGUEZ,; M.A.JASNIS,; A.M.EIJÁN,; S.OISGOLD-DAGÁ,; E.S.DE LUSTIG
Angiogenic activity by spleen cell supernatants from tumor-bearing and tumor-resected mice.
JOURNAL OF SURGICAL ONCOLOGY; Año: 1988 vol. 37 p. 44 - 48
L.DAVEL,; M.MIGUEZ,; M.A.JASNIS,; A.M.EIJÁN,; S.OISGOLD-DAGÁ,; S.KOHAN,; E.S.DE LUSTIG
Angiogenic activity from tumor-bearing mice: Nature of the spleen cells population capable of inducing neovascular response
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR.; Año: 1988 vol. 7 p. 111 - 117
M.A.JASNIS,; A.M.EIJÁN,; S.OISGOLD-DAGÁ
Regulation of growth by soluble spleen factors. Effects of tumor resection
JOURNAL OF SURGICAL ONCOLOGY; Año: 1987 vol. 35 p. 139 - 145
EIJAN AM; JASNIS MA,; KOHAN SS,; OISGOLD-DAGÁ S.
Nature of the spleen cell populations capable of releasing tumor enhancing factor
JOURNAL OF SURGICAL ONCOLOGY; Año: 1987 vol. 36 p. 161 - 165
A.M.EIJÁN,; E.BAL DE KIER JOFFÉ,; L.PURICELLI,; D.ENTÍN,; D.VUOTO,; E.ORLANDO,; E.S.DE LUSTIG
Serial analysis of fibronectin concentration in plasma of patients with benign and malignant breast diseases
CANCER; Año: 1986 vol. 57 p. 1345 - 1349
L.PURICELLI,; E.BAL DE KIER JOFFÉ,; A.M.EIJÁN,; D.ENTÍN,; E.S.DE LUSTIG
Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastatisizing ability
CANCER LETTERS; Año: 1985 vol. 29 p. 189 - 195